Unlike common SAMS, which are typically benign and resolve after statin discontinuation, anti-HMGCR IMNM causes persistent proximal weakness and elevated CK levels, requiring immunosuppressive therapy. Here, HMGCR is linked to short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.